| 000 | 01750 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517213352.0 | ||
| 264 | 0 | _c20200327 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1600-0536 | ||
| 024 | 7 |
_a10.1111/cod.13000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Risi-Pugliese, Tullia | |
| 245 | 0 | 0 |
_aEyelid allergic contact dermatitis after intravitreal injections of anti-vascular endothelial growth factor: What is the culprit? A report of 3 cases. _h[electronic resource] |
| 260 |
_bContact dermatitis _cAug 2018 |
||
| 300 |
_a103-104 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAzithromycin _xadministration & dosage |
| 650 | 0 | 4 |
_aBlepharitis _xchemically induced |
| 650 | 0 | 4 |
_aDermatitis, Allergic Contact _xdiagnosis |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aDrug Eruptions _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aRanibizumab _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aAmsler, Emmanuelle | |
| 700 | 1 | _aCollet, Evelyne | |
| 700 | 1 | _aFrancès, Camille | |
| 700 | 1 | _aBarbaud, Annick | |
| 700 | 1 | _aPecquet, Catherine | |
| 700 | 1 | _aSoria, Angèle | |
| 773 | 0 |
_tContact dermatitis _gvol. 79 _gno. 2 _gp. 103-104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cod.13000 _zAvailable from publisher's website |
| 999 |
_c28339297 _d28339297 |
||